NCT03774433

Brief Summary

This study will evaluate the degree to which engaging targets produces a desired change in medical regimen adherence (across 4-week interventions) and health behavior among smokers (n=50) and overweight/obese persons with binge eating disorder (n=50) (smoking in the former sample and binge eating in the latter sample). The investigators will employ a novel mobile behavioral assessment/intervention platform to engage targets in these samples, given that (1) it offers self-regulation assessment and behavior change tools via an integrated platform to a wide array of populations, and (2) content within the platform can be quickly modified as needed to better impact targets. This is the fourth and final phase of a study that aims to identify putative mechanisms of behavior change to develop an overarching "ontology" of self-regulatory processes. This trial builds on NCT03352713.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 13, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

February 27, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 29, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 29, 2020

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

August 24, 2021

Completed
Last Updated

August 24, 2021

Status Verified

July 1, 2021

Enrollment Period

1.3 years

First QC Date

December 11, 2018

Results QC Date

June 29, 2021

Last Update Submit

July 29, 2021

Conditions

Keywords

self-regulationbinge eatingsmokingecological momentary assessmentmobile sensingmHealth

Outcome Measures

Primary Outcomes (2)

  • Rate of Binge Eating Episodes [Binge Eating Sample Only]

    \[Binge eating sample only\] Self-reported binge eating episodes are assessed four times daily (morning, early afternoon, late afternoon/evening, and night) over a 28-day period. A binge eating episode is defined as self-reported overeating and loss of control. Overeating is assessed by the question "Since the last prompt, when you ate most recently, did you overeat?" and is scored as 0 (no) or 1 (yes). Loss of control is assessed by the question "When you ate most recently, did you lose control over your eating?" and is scored as 1 (not at all) to 5 (totally), where a 4 or 5 is considered loss of control. We are reporting the mean and standard deviations of the target behavior for each sample by week (i.e., Week 1, Week 2, Week 3, and Week 4). Data were averaged for all assessments each week to calculate the number of binge-eating episodes per week.

    28 days

  • Rate of Smoking Episodes [Smoking Sample Only]

    \[Smoking sample only\] Self-reported smoking is assessed four times daily (morning, early afternoon, late afternoon/evening, and night) over a 28-day period. A smoking episode is defined as self-reported smoking of more than zero cigarettes and is assessed by the question "Since the last prompt, how many cigarettes have you smoked?" Participants are asked to input a number into a number field. We are reporting the mean and standard deviations of the target behavior for each sample by week (i.e., Week 1, Week 2, Week 3, and Week 4). Data were averaged for all assessments each week to calculate the number of cigarettes smoked per week.

    28 days

Study Arms (1)

Laddr

EXPERIMENTAL

All participants in the study will be invited to use Laddr, described in the intervention section.

Behavioral: Laddr

Interventions

LaddrBEHAVIORAL

Laddr is an integrated, personalized, web-based self-regulation assessment and behavior change system. It integrates tools that have been shown to be effective for a wide array of behavioral phenomena ranging from substance use and abuse, mental health, risk-taking, chronic pain management, medication adherence, diet, exercise, diabetes and other chronic disease management, and smoking. The organizational structure, functionality and content within Laddr's system centrally embrace these fundamental aspects of behavior change; thus, the Laddr platform is not "diagnosis-specific" but rather enables integrated care for any combination of individuals' goals, needs, and preferences.

Laddr

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-50 years
  • Understand English sufficiently to provide informed consent
  • Access to a computer in a setting in which the participant is comfortable providing sensitive information
  • Use a smartphone operating system compatible with Laddr
  • ≤ BMI ≤ 45 kg/m2
  • Have binge eating disorder according to DSM-5 criteria
  • Non-smoking (defined as no cigarettes in past 12 months-this includes former and never smokers)
  • Confirmed interest in an eating intervention
  • Use a smartphone compatible with Fitbit
  • Smoke 5 or more tobacco cigarettes/day for past year
  • ≤ BMI \< 27 kg/m2
  • Confirmed interest in a smoking quit attempt
  • Use a smartphone compatible with the iCO Smokerlyzer

You may not qualify if:

  • Enrolled in Aim 2 study
  • Any current substance use disorder
  • o Will not exclude based on use of substances
  • Currently pregnant or plans to become pregnant in next 3 months
  • Lifetime history of mental disorder due to a medical condition
  • Lifetime history of major psychotic disorders (including schizophrenia and bipolar disorder)
  • Current use of prescription pain medications (e.g., Vicodin, oxycodone)
  • Current use of any medication for smoking (e.g., Wellbutrin, varenicline)
  • o Exceptions: will not screen out for nicotine replacement therapy (e.g., patch, gum, lozenge, nasal spray, inhaler)
  • Current use of any medication for weight loss
  • Have undergone weight-loss surgery (e.g., gastric bypass, lap band)
  • Current nighttime shift work or obstructive sleep apnea
  • Note: We will not exclude based on e-cigarette use.
  • Compensatory behavior (e.g., purging, excessive exercise, fasting)
  • o Already excluded as part of the DSM-5 binge eating disorder criteria
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Technology and Behavioral Health, Dartmouth College

Lebanon, New Hampshire, 03766, United States

Location

Related Publications (1)

  • Plaitano EG, McNeish D, Bartels SM, Bell K, Dallery J, Grabinski M, Kiernan M, Lavoie HA, Lemley SM, Lowe MR, MacKinnon DP, Metcalf SA, Onken L, Prochaska JJ, Sand CL, Scherer EA, Stoeckel LE, Xie H, Marsch LA. Adherence to a digital therapeutic mediates the relationship between momentary self-regulation and health risk behaviors. Front Digit Health. 2025 Feb 4;7:1467772. doi: 10.3389/fdgth.2025.1467772. eCollection 2025.

MeSH Terms

Conditions

Self-ControlBulimiaSmoking

Condition Hierarchy (Ancestors)

Social BehaviorBehaviorHyperphagiaSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Lisa Marsch
Organization
Dartmouth College

Study Officials

  • Lisa A Marsch, PhD

    Dartmouth College

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Andrew G. Wallace Professor; Director, Center for Technology and Behavioral Health

Study Record Dates

First Submitted

December 11, 2018

First Posted

December 13, 2018

Study Start

February 27, 2019

Primary Completion

June 29, 2020

Study Completion

June 29, 2020

Last Updated

August 24, 2021

Results First Posted

August 24, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will share

After completion of the study, a de-identified dataset (i.e., stripped of all codes and other information that could be linked back to an individual participant) will be generated and made available to the research community as a whole. Informed consent procedures will ensure that participants are aware that consenting to participate in the study means consenting to inclusion in this open data set.

Time Frame
Data will be available upon submission of the paper detailing the findings of the research.
Access Criteria
All data will be shared openly with no restrictions on access.

Locations